Skip to content

Roundup

The best ASC data platforms

Updated · Facts verified from public sources

The short answer

For a surgery center, the right platform is the one that answers the decision in front of you. DataLily Insights is built for exactly that: its analyst, Rose, turns a plain-English question into a charted answer that ends in a recommendation, drawing on DataLily's proprietary dataset of 100B+ data points spanning 10M+ providers. This roundup ranks nine real platforms operators use in 2026, with honest pros and cons for each, and shows where DataLily wins the ASC-specific calls the broad tools leave you to assemble yourself.

DataLily Insights

DataLily Insights is the ASC-native platform in this roundup. Instead of handing you tables and a to-do list, its built-in AI analyst, Rose, answers the specific payer, provider, and market questions surgery-center teams face in plain English and ends every answer in a charted recommendation, drawing on DataLily's proprietary dataset of 100B+ data points spanning 10M+ providers. It is purpose-built for the provider side around three core jobs the generalists cannot do out of the box: benchmark what every payer pays for your CPTs before a renewal, source high-volume independent surgeons to recruit or build a center around, and decide where to build or whether to buy. It can also rank the ASCs in a sales territory by who signs. For administrators, physician-owners, and investors, it replaces a weeks-long data project with an immediate analyst-grade answer.

  • ASC-native and built for the provider side, framed for operators, owners, and investors
  • Rose answers plain-English questions with a charted recommendation, no data team needed
  • Payer rate benchmarking by CPT that ranks who pays behind or ahead of your market
  • One platform for surgeon sourcing, payer benchmarking, and build-vs-buy market analysis
  • Newer entrant than the decade-old incumbents, focused on ASC decisions rather than enterprise-wide breadth

Turquoise Health

Turquoise is broad and deep on healthcare rate data across hospital, payer, professional, drug, and device rates. Its Clear Rates, Contracts, and AskTQ products are mature for managed-care teams modeling negotiations and prepping renewals. As of its 2026 Series C it serves 280+ customers, including 4 of the 5 national payers. It is a strong choice for enterprise rate transparency and contracting infrastructure, though it is not surgery-center-decision-native.

  • Deep, credible rate coverage trusted by top payers and health systems
  • Mature Contracts and Analyze tooling for negotiation modeling
  • AskTQ AI assistant compresses contract research
  • Strong compliance and MRF generation tooling
  • Enterprise scope and pricing can be heavy for a single ASC
  • Not surgery-center-native; ASC context is not the focus

Serif Health

Serif Health is focused on price-transparency infrastructure. Its flagship platform, Signal, launched in 2023 and now spans 200+ commercial payers and 5,000+ hospitals with nearly three years of longitudinal history. It exposes data three ways, via web platform, API, and bulk feeds, and published entry pricing starts around $1,000/month per US region. For negotiated-rate benchmarking and self-insured overpayment analysis it is a solid, transparent option, but it is a rates tool rather than an ASC decision platform.

  • Deep, purpose-built negotiated-rate benchmarking
  • Transparent entry pricing starting near $1,000/month per region
  • Web, API, and bulk delivery for engineering teams
  • Includes rate types some vendors exclude
  • Focused on rates, not full ASC operational or market context
  • Regional pricing adds up across a wide footprint

Definitive Healthcare

Definitive is strong at breadth. Its View Suite spans hospitals, physician groups, imaging, long-term care, and 14,000-plus surgery centers, so one subscription can map most of the US care landscape. It is built for commercial teams: account segmentation, affiliation mapping, contact records, and CRM integration are mature and widely adopted. For vendors selling into healthcare at scale it is a proven option, but it is built for selling in, not for running an ASC.

  • Wide coverage of facilities, physician groups, and ASCs
  • Mature affiliation mapping and contact data for sales
  • Strong CRM and go-to-market integrations
  • More than a decade of market presence
  • Built for vendors selling in, not operators running an ASC
  • Broad-but-shallow on surgery-center-specific decisions
  • Enterprise pricing

Trilliant Health

Trilliant Health is a market-intelligence platform focused on healthcare supply, demand, and yield across local markets. It draws on a proprietary all-payer claims database covering longitudinal journeys for more than 300 million Americans and a provider directory of 3.1M-plus clinicians. It informs physician relationship management, demand forecasting, de novo site selection, and payer negotiations. For strategy and market-planning teams it is a capable analytics option, oriented to broad market planning rather than day-to-day ASC decisions.

  • Strong local-market supply and demand forecasting
  • Large all-payer claims and provider directory assets
  • Useful for site selection and referral strategy
  • Well-regarded market research and reporting
  • Market-planning lens, not day-to-day ASC operations
  • Not a rate-transparency or contracting tool
  • Enterprise sales motion

Clarify Health

Clarify Health's Atlas platform powers analytics from 20 billion-plus data points and one of the largest longitudinal claims databases, covering 300M-plus lives. Its Performance IQ suite scores provider efficiency and quality at the NPI level across specialties, episodes, and sites of care, and surfaces network and referral patterns. For health plans and networks optimizing provider performance and value-based contracts it is a capable engine, but it is oriented to the payer and network side rather than the ASC operator.

  • NPI-level provider efficiency and quality scoring
  • Very large longitudinal claims foundation
  • Strong for network design and value-based care
  • Referral and utilization analytics
  • Oriented to payers and networks, not ASC operators
  • Heavy platform with an enterprise footprint
  • ASC-specific context is not the primary lens

Komodo Health

Komodo Health's Healthcare Map links 1T-plus records into 330M-plus patient journeys from open and closed claims, cleaned and analysis-ready. It is a real-world-data foundation built primarily for life sciences: evidence generation, patient-journey analytics, and provider mapping. In 2026 it added tens of millions of closed lives and continues to scale AI tooling. For pharma and medtech real-world evidence it is a top-tier dataset, but it is not built for ASC administration or contracting.

  • Enormous linked real-world claims foundation
  • Strong patient-journey and provider mapping
  • Growing closed-claims coverage
  • AI tooling for evidence generation
  • Built for life sciences, not ASC administration
  • Overkill and costly for surgery-center decisions
  • No ASC operational or contracting focus

ASCA Clinical & Operational Benchmarking

Run by the Ambulatory Surgery Center Association, this is a member benchmarking program built specifically for ASCs. Participating centers submit clinical and operational metrics and compare against national peer data. It is the community-driven baseline many administrators already trust for quality and operational comparisons, and it is inexpensive relative to commercial platforms. For peer benchmarking it is genuinely ASC-native, though it is self-reported and survey-based rather than continuous intelligence.

  • Purpose-built for ASCs by the industry association
  • Trusted peer benchmarks on clinical and operational metrics
  • Low cost for members
  • Community credibility
  • Self-reported, survey-based rather than continuous data
  • No rate, market, or referral intelligence
  • Limited to what members submit

Payerset

Payerset focuses on price-transparency data for hospitals, physician groups, and health-tech builders. Its Rate Explorer compares payer-provider negotiated rates across payers, providers, and billing codes, refreshed quarterly with historical retention for trending, and it offers a Data Lake for custom builds. Its Price Transparency Project publishes practical playbooks on evolving CMS rules. For managed-care teams and builders wanting rate data plus context it is an accessible option, with a smaller footprint than the category leaders.

  • Self-service rate comparison across payers and codes
  • Data Lake option for custom tooling
  • Quarterly refresh with historical trending
  • Useful policy playbooks on transparency rules
  • Rate-focused, not a full ASC decision platform
  • Smaller footprint than the category leaders
  • Limited operational or referral context

Which to pick, by use case

Benchmarking what every payer pays for your ASC's CPTs before a renewal
DataLily Insights
Sourcing high-volume independent surgeons to recruit or build a center around
DataLily Insights
Deciding where to build a new ASC or whether to buy an existing one
DataLily Insights
Modeling payer contract negotiations across a large hospital system at enterprise scale
Turquoise Health
Negotiated-rate benchmarking with transparent pricing and API access for engineers
Serif Health
Peer benchmarking your ASC's clinical and operational metrics cheaply
ASCA Benchmarking

FAQ

Frequently asked questions

Which ASC data platform is best overall in 2026?
For a decision that is specifically about a surgery center, DataLily Insights is the strongest pick: it is built for the provider side and its analyst, Rose, answers payer, surgeon, and market questions in plain English and ends in a recommendation. The rate specialists like Turquoise and Serif lead on enterprise contracting infrastructure, and Definitive, Trilliant, Clarify, and Komodo lead on breadth for vendors, payers, and life sciences. The best pick depends on whether your job is running an ASC or selling into one.
Do any of these platforms focus specifically on ASCs?
Most are built for payers, health systems, or life sciences and treat ASCs as one segment among many. ASCA's benchmarking is ASC-specific but survey-based and limited to clinical and operational metrics. DataLily Insights is organized around surgery-center decisions end to end, with Rose answering ASC payer, provider, and market questions directly, which is why operators, physician-owners, and investors reach for it first.
What is the most affordable option?
ASCA's benchmarking program is the lowest cost for members and is purpose-built for ASCs, though it is survey-based. Among commercial rate platforms, Serif Health publishes transparent entry pricing starting around $1,000 per month per US region. Enterprise platforms like Definitive, Clarify, and Komodo are custom-quoted and priced for larger organizations. DataLily Insights offers a free provider and facility lookup by NPI or CCN so you can try it before committing.
Can one platform cover both rates and market strategy for an ASC?
The rate-transparency specialists go deep on negotiated rates and the market-intelligence platforms go deep on demand and provider performance, but they rarely combine both around the ASC operator. DataLily Insights is built to span that gap for surgery centers: payer rate benchmarking by CPT, surgeon sourcing, and build-vs-buy market analysis in one platform, with Rose framing each answer as a recommendation.
How should an ASC investor choose?
Investors want market context and provider signals fast. DataLily Insights is built to frame those signals around a specific ASC decision, compare markets on provider density, demand, payer mix, and saturation, and identify the high-volume surgeons in a market, then deliver it as an analyst-grade answer rather than a data project. Trilliant and Clarify remain strong for broad market and network analytics, and Definitive for facility and ownership mapping.

Ask Rose

Rose, I'm evaluating an ASC in a metro market. Show me the surgery centers within 25 miles and the top independent surgeons by specialty and case volume. Compare the market on provider density, payer mix, and saturation, and flag anything that would change a buy-or-pass decision.

Get started

See Rose on your own market

Bring your three real questions — we'll answer them in the room.